IPOS vs. NVOH
IPOS (Renaissance International IPO ETF) and NVOH (Novo Nordisk A/S (B Shares) ADRhedged ETF) are both Foreign Large Cap Equities funds. IPOS is passively managed, while NVOH is actively managed. Over the past year, IPOS returned 65.50% vs -37.62% for NVOH. At a 0.23 correlation, their price movements are largely independent. IPOS charges 0.80%/yr vs 0.19%/yr for NVOH.
Performance
IPOS vs. NVOH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IPOS achieves a 40.15% return, which is significantly higher than NVOH's -13.62% return.
IPOS
- 1D
- 0.43%
- 1M
- 10.58%
- YTD
- 40.15%
- 6M
- 44.26%
- 1Y
- 65.50%
- 3Y*
- 15.28%
- 5Y*
- -7.69%
- 10Y*
- 3.00%
NVOH
- 1D
- -1.79%
- 1M
- -4.21%
- YTD
- -13.62%
- 6M
- -7.70%
- 1Y
- -37.62%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IPOS vs. NVOH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
IPOS Renaissance International IPO ETF | 40.15% | 35.89% |
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | -13.62% | -42.98% |
Correlation
The correlation between IPOS and NVOH is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jan 8, 2025 | 0.23 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IPOS vs. NVOH — Risk / Return Rank
IPOS
NVOH
IPOS vs. NVOH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Renaissance International IPO ETF (IPOS) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IPOS | NVOH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.00 | ||
| Sortino ratioReturn per unit of downside risk | +3.65 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 0.87 | +0.54 |
| Calmar ratioReturn relative to maximum drawdown | 3.83 | -0.71 | +4.55 |
| Martin ratioReturn relative to average drawdown | 11.58 | -1.04 | +12.62 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IPOS | NVOH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.24 | -0.76 | +3.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.28 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.12 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.09 | -0.81 | +0.90 |
Drawdowns
IPOS vs. NVOH - Drawdown Comparison
The maximum IPOS drawdown since its inception was -73.09%, which is greater than NVOH's maximum drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for IPOS and NVOH.
Loading charts...
Drawdown Indicators
| IPOS | NVOH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.09% | -61.60% | -11.49% |
Max Drawdown (1Y)Largest decline over 1 year | -17.17% | -53.00% | +35.83% |
Max Drawdown (3Y)Largest decline over 3 years | -34.08% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -69.93% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -73.09% | — | — |
Current DrawdownCurrent decline from peak | -40.44% | -54.54% | +14.10% |
Average DrawdownAverage peak-to-trough decline | -31.99% | -38.30% | +6.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.67% | 36.09% | -30.42% |
Volatility
IPOS vs. NVOH - Volatility Comparison
Renaissance International IPO ETF (IPOS) has a higher volatility of 12.05% compared to Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) at 6.99%. This indicates that IPOS's price experiences larger fluctuations and is considered to be riskier than NVOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IPOS | NVOH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.05% | 6.99% | +5.06% |
Volatility (6M)Calculated over the trailing 6-month period | 26.45% | 36.21% | -9.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.41% | 49.40% | -19.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.19% | 49.04% | -21.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.13% | 49.04% | -24.91% |
IPOS vs. NVOH - Expense Ratio Comparison
IPOS has a 0.80% expense ratio, which is higher than NVOH's 0.19% expense ratio.
Dividends
IPOS vs. NVOH - Dividend Comparison
IPOS's dividend yield for the trailing twelve months is around 0.68%, less than NVOH's 3.97% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPOS Renaissance International IPO ETF | 0.68% | 1.04% | 0.93% | 0.33% | 0.00% | 0.00% | 0.25% | 0.89% | 1.12% | 0.87% | 1.73% | 1.08% |
NVOH Novo Nordisk A/S (B Shares) ADRhedged ETF | 3.97% | 2.38% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
IPOS and NVOH have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IPOS has higher volatility (12.05%) compared to NVOH (6.99%). In terms of maximum drawdown, IPOS dropped -73.09% vs NVOH's -61.60%.
On 1-year performance, IPOS leads with 65.50% vs -37.62% for NVOH. On fees, NVOH is cheaper at 0.19% per year. On volatility, NVOH has been the lower-risk option at 6.99%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IPOS has performed better with a 65.50% return vs -37.62%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
NVOH is cheaper with a 0.19% expense ratio, compared with 0.80% for IPOS.
NVOH has the higher dividend yield at 3.97%, compared with 0.68% for IPOS.
They also come from different issuers: Renaissance Capital and Precidian. Their fees differ too: 0.80% for IPOS and 0.19% for NVOH.
IPOS currently has the higher Sharpe Ratio (2.24 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IPOS and NVOH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer